Kir2.1 Antibody (2153C)
R&D Systems | Catalog # MAB9548
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Asn352-Ile427
Accession # P63252
Specificity
Clonality
Host
Isotype
Scientific Data Images for Kir2.1 Antibody (2153C)
Detection of Human Kir2.1 by Western Blot.
Western blot shows lysates of Human heart ventricle tissue and human lung tissue. PVDF membrane was probed with 3 µg/mL of Rabbit Anti-Human/Mouse Kir2.1 Monoclonal Antibody (Catalog # MAB9548) followed by HRP-conjugated Anti-Rabbit IgG Secondary Antibody (Catalog # HAF008). A specific band was detected for Kir2.1 at approximately 50-55 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.Kir2.1 in Human Heart.
Kir2.1 was detected in immersion fixed paraffin-embedded sections of human heart using Rabbit Anti-Human/Mouse Kir2.1 Monoclonal Antibody (Catalog # MAB9548) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Rabbit IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC003). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to intercalated discs. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.Kir2.1 in Mouse Heart.
Kir2.1 was detected in perfusion fixed frozen sections of mouse heart using Rabbit Anti-Human/Mouse Kir2.1 Monoclonal Antibody (Catalog # MAB9548) at 3 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Rabbit IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC003). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to intercalated discs. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.Kir2.1 in Human Cardiomyocytes.
Kir2.1 was detected in immersion fixed human cardiomyocytes using Rabbit Anti-Human/Mouse Kir2.1 Monoclonal Antibody (Catalog # MAB9548) at 2 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Rabbit IgG Secondary Antibody (red; Catalog # NL004) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.Detection of Kir2.1 by Western Blot
Mitochondrial TCA cycle enzymes translocate to the nucleus upon doxorubicin treatment. A, b Confocal microscopy images of hiPSC-derived cardiomyocytes treated with 1 µM doxorubicin for 6 or 24 h (DRN) or DMSO (control). The cells were stained with anti-isocitrate dehydrogenase (IDH-2) (a) or anti-citrate synthase (CS) (b) and detected with a secondary antibody conjugated with Alexa 594. Cells were stained with CoxIV and Troponin-T (TnT) as markers for mitochondria and cardiomyocytes, respectively. The signals from CoxIV and TnT were detected with secondary antibodies conjugated with Alexa-633 and Alexa-488, respectively. Scale bar: 20 µm. c–f 3-dimensional reconstituted z-stack images of control (c, e) and doxorubicin-treated cells (d, f) stained for MDH-2 (c, d) and IDH-2 (e, f), CoxIV, and TnT. Scale bar: 10 µm. g Immunoblots demonstrating the nuclear localization of IDH-3, PDH-E1, and MDH-2 in the nuclear fraction from cells treated with doxorubicin (DRN) for 6 or 24 h or from DMSO-treated control cells. TnT and Kir2.1 were probed to rule out the contamination of cytoplasmic fractions, and CoxIV was used as a mitochondrial marker in the isolated nuclear lysate. Whole-cell lysates from untreated cells were used as another control. h, i Immunostained images of cardiomyocytes isolated from mice treated with vehicle (h) or doxorubicin (i) for 72 h, cells stained for IDH-2, CoxIV, and TnT. Scale bar: 10 µm; images are represented along with the three-dimensional reconstruction of z-stack images. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37468519), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of Kir2.1 by Western Blot
Mitochondrial TCA cycle enzymes translocate to the nucleus upon doxorubicin treatment. A, b Confocal microscopy images of hiPSC-derived cardiomyocytes treated with 1 µM doxorubicin for 6 or 24 h (DRN) or DMSO (control). The cells were stained with anti-isocitrate dehydrogenase (IDH-2) (a) or anti-citrate synthase (CS) (b) and detected with a secondary antibody conjugated with Alexa 594. Cells were stained with CoxIV and Troponin-T (TnT) as markers for mitochondria and cardiomyocytes, respectively. The signals from CoxIV and TnT were detected with secondary antibodies conjugated with Alexa-633 and Alexa-488, respectively. Scale bar: 20 µm. c–f 3-dimensional reconstituted z-stack images of control (c, e) and doxorubicin-treated cells (d, f) stained for MDH-2 (c, d) and IDH-2 (e, f), CoxIV, and TnT. Scale bar: 10 µm. g Immunoblots demonstrating the nuclear localization of IDH-3, PDH-E1, and MDH-2 in the nuclear fraction from cells treated with doxorubicin (DRN) for 6 or 24 h or from DMSO-treated control cells. TnT and Kir2.1 were probed to rule out the contamination of cytoplasmic fractions, and CoxIV was used as a mitochondrial marker in the isolated nuclear lysate. Whole-cell lysates from untreated cells were used as another control. h, i Immunostained images of cardiomyocytes isolated from mice treated with vehicle (h) or doxorubicin (i) for 72 h, cells stained for IDH-2, CoxIV, and TnT. Scale bar: 10 µm; images are represented along with the three-dimensional reconstruction of z-stack images. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37468519), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Kir2.1 Antibody (2153C)
Immunocytochemistry
Sample: Immersion fixed human cardiomyocytes
Immunohistochemistry
Sample: Immersion fixed paraffin-embedded sections of human heart and perfusion fixed frozen sections of mouse heart
Western Blot
Sample: Human heart ventricle tissue and lung tissue
Reviewed Applications
Read 1 review rated 5 using MAB9548 in the following applications:
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: Kir2.1
Long Name
Alternate Names
Gene Symbol
UniProt
Additional Kir2.1 Products
Product Documents for Kir2.1 Antibody (2153C)
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Kir2.1 Antibody (2153C)
For research use only
Related Research Areas
Citations for Kir2.1 Antibody (2153C)
Customer Reviews for Kir2.1 Antibody (2153C) (1)
Have you used Kir2.1 Antibody (2153C)?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 for a review with an image
$10/€7/£6/$10CAN/¥1110 for a review without an image
Submit a review
Customer Images
-
Application: ImmunofluorescenceSample Tested: Cardiac ventricular tissueSpecies: MouseVerified Customer | Posted 12/08/2021
There are no reviews that match your criteria.
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Antigen Retrieval Protocol (PIER)
- Antigen Retrieval for Frozen Sections Protocol
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- Chromogenic IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Chromogenic Immunohistochemistry Staining of Frozen Tissue
- ClariTSA™ Fluorophore Kits
- Detection & Visualization of Antibody Binding
- Fluorescent IHC Staining of Frozen Tissue Protocol
- Graphic Protocol for Heat-induced Epitope Retrieval
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Graphic Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- ICC Cell Smear Protocol for Suspension Cells
- ICC Immunocytochemistry Protocol Videos
- ICC for Adherent Cells
- IHC Sample Preparation (Frozen sections vs Paraffin)
- Immunocytochemistry (ICC) Protocol
- Immunocytochemistry Troubleshooting
- Immunofluorescence of Organoids Embedded in Cultrex Basement Membrane Extract
- Immunofluorescent IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Immunohistochemistry Frozen Troubleshooting
- Immunohistochemistry Paraffin Troubleshooting
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Protocol for Heat-Induced Epitope Retrieval (HIER)
- Protocol for Making a 4% Formaldehyde Solution in PBS
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Fluorescent ICC Staining of Cell Smears - Graphic
- Protocol for the Fluorescent ICC Staining of Cultured Cells on Coverslips - Graphic
- Protocol for the Preparation & Fixation of Cells on Coverslips
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections - Graphic
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections - Graphic
- Protocol for the Preparation and Fluorescent ICC Staining of Cells on Coverslips
- Protocol for the Preparation and Fluorescent ICC Staining of Non-adherent Cells
- Protocol for the Preparation and Fluorescent ICC Staining of Stem Cells on Coverslips
- Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- Protocol for the Preparation of a Cell Smear for Non-adherent Cell ICC - Graphic
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Immunohistochemistry
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars